Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer—a nationwide analysis

Author:

Grilz Ella12ORCID,Posch Florian13,Nopp Stephan1ORCID,Königsbrügge Oliver1,Lang Irene M4ORCID,Klimek Peter5ORCID,Thurner Stefan567,Pabinger Ingrid1,Ay Cihan1ORCID

Affiliation:

1. Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria

2. Department of Anesthesiology and Intensive Care, Danube Hospital, Langobardenstraße 122, Vienna 1220, Austria

3. Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 1, Graz 8036, Austria

4. Clinical Division of Cardiology, Department of Medicine II, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna 1090, Austria

5. Section for Science of Complex Systems, CEMSIIS, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria

6. Santa Fe Institute, 1399 Hyde Park Road, Santa Fe, NM 85701, USA

7. IIASA, Schlossplatz 1, Laxenburg 2361, Austria

Abstract

Abstract Aims An interrelation between cancer and thrombosis is known, but population-based studies on the risk of both arterial thromboembolism (ATE) and venous thromboembolism (VTE) have not been performed. Methods and results International Classification of Disease 10th Revision (ICD-10) diagnosis codes of all publicly insured persons in Austria (0–90 years) were extracted from the Austrian Association of Social Security Providers dataset covering the years 2006–07 (n = 8 306 244). Patients with a history of cancer or active cancer were defined as having at least one ICD-10 ‘C’ diagnosis code, and patients with ATE and/or VTE as having at least one of I21/I24 (myocardial infarction), I63/I64 (stroke), I74 (arterial embolism), and I26/I80/I82 (venous thromboembolism) diagnosis code. Among 158 675 people with cancer, 8559 (5.4%) had an ATE diagnosis code and 7244 (4.6%) a VTE diagnosis code. In contrast, among 8 147 569 people without cancer, 69 381 (0.9%) had an ATE diagnosis code and 29 307 (0.4%) a VTE diagnosis code. This corresponds to age-stratified random-effects relative risks (RR) of 6.88 [95% confidence interval (CI) 4.81–9.84] for ATE and 14.91 (95% CI 8.90–24.95) for VTE. ATE proportion was highest in patients with urinary tract malignancies (RR: 7.16 [6.74–7.61]) and lowest in patients with endocrine cancer (RR: 2.49 [2.00–3.10]). The corresponding VTE proportion was highest in cancer of the mesothelium/soft tissue (RR: 19.35 [17.44–21.47]) and lowest in oropharyngeal cancer (RR: 6.62 [5.61–7.81]). Conclusion The RR of both ATE and VTE are significantly higher in persons with cancer. Our population-level meta-data indicate a strong association between cancer, ATE and VTE, and support the concept of shared risk factors and pathobiology between these diseases. Relative risk of ATE and VTE in persons with a cancer diagnosis code versus persons without a cancer diagnosis code.

Funder

Austrian Science Fund

Special Research Program

Austrian science fund

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3